BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE and URINARY TRACT INFECTION

Overview

URINARY TRACT INFECTION is the #12 most commonly reported adverse reaction for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, manufactured by Padagis Israel Pharmaceuticals Ltd. There are 5 FDA adverse event reports linking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE to URINARY TRACT INFECTION. This represents approximately 2.0% of all 256 adverse event reports for this drug.

Patients taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE who experience urinary tract infection should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

URINARY TRACT INFECTION is a less commonly reported adverse event for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE

In addition to urinary tract infection, the following adverse reactions have been reported for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE:

• DRUG HYPERSENSITIVITY — 10 reports
• DRUG INEFFECTIVE — 10 reports
• PRURITUS — 7 reports
• CONSTIPATION — 6 reports
• OFF LABEL USE — 6 reports
• RASH — 6 reports
• DYSPNOEA — 5 reports
• FATIGUE — 5 reports
• MALAISE — 5 reports
• NAUSEA — 5 reports

Other Drugs Associated with URINARY TRACT INFECTION

The following drugs have also been linked to urinary tract infection in FDA adverse event reports:

Does BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE cause URINARY TRACT INFECTION?

URINARY TRACT INFECTION has been reported as an adverse event in 5 FDA reports for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is URINARY TRACT INFECTION with BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE?

URINARY TRACT INFECTION accounts for approximately 2.0% of all adverse event reports for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience URINARY TRACT INFECTION while taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE?

If you experience urinary tract infection while taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages